Perl Jessica 4

What Happened
Jessica Perl, SVP, General Counsel and Corporate Secretary of Emergent BioSolutions (EBS), was granted 104,282 restricted stock units (RSUs) on April 29, 2026. The award is reported as an acquisition (code A) at $0.00 per share (no cash paid). Each RSU represents the right to receive one share of EBS common stock, subject to adjustment under the grant agreement.

Key Details

• Transaction date: 2026-04-29; 104,282 restricted stock units granted at $0.00 per RSU.
• Filing date: Form 4 filed 2026-05-01 (reported timely).
• Shares owned after the transaction: not specified in the Form 4 provided.
• Footnotes: (1) Grant was approved by the Compensation Committee on March 2, 2026, subject to shareholder approval of an amendment to the 2006 Stock Incentive Plan; shareholders approved the amendment on April 29, 2026. (2) RSUs vest in three annual installments beginning on the anniversary of the date of approval, assuming continued service; each RSU converts to one share when vested.

Context
This is a compensation award (long-term incentive), not an open-market purchase or sale. RSU grants align executive pay with future company performance and typically vest over time; they do not immediately transfer shares or indicate an immediate cash investment by the insider.